Close menu




April 3rd, 2023 | 15:59 CEST

Range of up to 2,000 km - Hydrogen comeback? Volkswagen, dynaCERT, NEL

  • Hydrogen
  • fuelcell
  • Technology
Photo credits: pixabay.com

Car manufacturers like Volkswagen apply for a whole series of patents every year. Many of them never become relevant. A few months ago, however, Volkswagen and a partner company filed a hydrogen patent that is quite something. There is talk of a fuel cell that, thanks to a ceramic membrane, is more efficient and enables ranges of up to 2,000 km for one tankful. Will the patent bring about the hydrogen revolution in private transport? We analyse the situation and look at three listed companies.

time to read: 2 minutes | Author: Nico Popp
ISIN: VOLKSWAGEN AG VZO O.N. | DE0007664039 , DYNACERT INC. | CA26780A1084 , NEL ASA NK-_20 | NO0010081235

Table of contents:


    Bernd Krueper, President & Director, dynaCERT Inc.
    "[...] dynaCERT's HydraGEN™ device offers a retrofit solution for diesel engines designed to protect the environment while providing economic benefits. [...]" Bernd Krueper, President & Director, dynaCERT Inc.

    Full interview

     

    Volkswagen: Is the super fuel cell coming?

    The very fact that Volkswagen has not put hydrogen research on the back burner proves that hydrogen technology still has potential. The new patent for a ceramic membrane in fuel cells is supposed to make lithium redundant and also manage without platinum. That alone should make new fuel cells manufactured using this process cheaper. Kraftwerk Tubes GmbH, which holds the patent together with Volkswagen, wants to see series-production vehicles with the technology by 2026 and considers collaborations with several manufacturers possible. However, it is unclear whether Volkswagen will soon be offering hydrogen cars. The Company points out that new patents do not necessarily have to lead to series production.

    In any case, it is more likely that other manufacturers will bring such models onto the market. Kraftwerk Tubes also cooperates with the Asian luxury manufacturer Infiniti, which belongs to Nissan. Nissan itself already has hydrogen cars on offer. However, the door for hydrogen vehicles is not entirely closed at Volkswagen either. The Company reserves the right to add such models to its product range, possibly in the second half of the decade. The planned MPE vehicle platform is to be equipped with both classic electric motors and fuel cells.

    dynaCERT: Customers rely on this hydrogen solution

    Technological innovations around hydrogen nevertheless have a signal effect, from which companies such as NEL, which is active in the production, storage and distribution of hydrogen, profit. The range of applications for hydrogen could become broader and broader in the coming years - for an all-round supplier like NEL, this is a good prospect. The fact that many industries have not yet committed to one technology is also positive for companies like dynaCERT. The Canadians offer conversion kits for heavy diesel engines. The patented HydraGEN technology ensures that a small amount of hydrogen is added to the classic diesel mixture. The end result is lower fuel consumption and CO2 savings. While sales of the solution for large fleet operators, such as transport companies, have been relatively slow in recent years, the Company has adapted its technology and is focusing on heavy machinery.

    Here, dynaCERT has struck a chord and was already able to book numerous orders last year, for example, from the mining industry. The good thing about dynaCERT's technology is that the Company documents and reports CO2 savings. Customers can then use these savings and are supposed to receive CO2 certificates in return. The certification process for dynaCERT is currently underway. If this hurdle is cleared, customers who have already bought the HydraGEN technology will have another argument in their favour. In recent years, the dynaCERT share price has followed the typical course of a growth stock - interrupted by steep rises, the price has crumbled. If the Company continues its operational successes or succeeds in obtaining certification for the generation of CO2 certificates, the share could be in for a new breakout. Investors with a knack for such stocks should keep dynaCERT on their radar.


    While dynaCERT is already selling its hydrogen solution to customers, hydrogen in cars remains an interesting thought experiment for most manufacturers. At the moment, however, VW's share price does not give rise to any hydrogen fantasy. However, the overall situation is favourable for "full-service providers" like NEL. Hydrogen remains an issue - also in individual transport. In addition to solution providers for transitional technology, such as dynaCERT, full-service hydrogen suppliers offer investors a promising perspective.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Fabian Lorenz on October 22nd, 2025 | 07:15 CEST

    HYDROGEN IS ALIVE! Bloom Energy, thyssenkrupp nucera, and dynaCERT! 1,000% not enough?

    • Hydrogen
    • greenhydrogen
    • cleantech
    • renewableenergies

    Plug Power has gained nearly 500% since May, proving that hydrogen is very much alive. The applications may be different from what was expected in the hype a few years ago - more specific and niche-focused. Investors are speculating that hydrogen will benefit from the energy boom driven by artificial intelligence. The same applies to Bloom Energy, whose stock has exploded by 1,000% over the past year. dynaCERT is active in an exciting niche, offering conversion kits for diesel engines ranging from trucks to container ships. Initial sales successes give hope for more. Will emission certificates follow? And what is Germany's hydrogen hope, thyssenkrupp nucera, doing? It remains in the shadow of TKMS. Still, one analyst sees upside potential of around 50%.

    Read

    Commented by Armin Schulz on October 22nd, 2025 | 07:05 CEST

    Bitcoin soars: How Strategy, Nakiki, and BlackRock are benefiting from the new MiCA regulation on tokenization

    • Bitcoin
    • Tokenization
    • crypto
    • Digitization
    • Technology

    Bitcoin is reaching new record highs. The hashrate is exploding, and analysts are predicting prices of USD 250,000. At the same time, the EU is establishing clear rules for tokenization through MiCA. This unique combination of technological strength and regulatory clarity is unleashing unprecedented institutional interest. Three companies are strategically positioned to capitalize on this boom: Strategy, Nakiki, and BlackRock. Here, we take a closer look at how these companies have positioned themselves.

    Read

    Commented by Nico Popp on October 22nd, 2025 | 07:00 CEST

    Important piece of the puzzle in the fight against cancer: Vidac Pharma, Roche, Merck & Co.

    • Biotechnology
    • Biotech
    • Pharma
    • Cancer
    • Technology
    • Innovations

    The pharmaceutical market is enormous - and continues to grow. Market research institute Evaluate forecasts an increase to around USD 1.7 trillion by 2030, representing an annual growth rate of 7.7%. Oncology promises the highest sales, at around USD 300 billion. However, there is no single approach. Instead, new modalities and technologies such as antibody-drug conjugates (ADCs), cell and gene therapies, and radiopharmaceuticals are transforming the industry and gaining significant traction. One thing is clear: progress in the biotech sector is increasingly achieved through the combination of active ingredients and technologies. What role does the biotech company Vidac Pharma play in this?

    Read